AVNS

Avanos Medical, Inc.
$24.98
+0.01 (+0.06%)
Mkt Cap 1.17B
Volume 84,271
52W Range 9.303-25.49
Sector Healthcare
Beta 1.57
EPS (TTM) -1.50
P/E Ratio -7.69
Revenue (TTM) 715.90M
Rev Growth (5Y) -0.4%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$17.44
Overvalued strong signal
43.2% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 701.20M 687.80M 673.30M 684.10M 744.60M 714.80M 697.60M 652.30M 611.60M 566.20M 1.57B 1.67B
Net Income (67.90M) (392.10M) (61.80M) 50.50M 6.30M (27.20M) (45.90M) 57.50M 79.30M 39.80M (426.30M) 27.10M
EPS -1.46 -8.53 -1.33 1.08 0.13 -0.57 -0.96 1.22 1.69 0.85 -9.15 0.58
Free Cash Flow 43.10M 82.90M 14.60M 71.60M 66.30M (22.70M) (125.10M) (194.70M) 101.00M 159.70M 27.20M 69.40M
FCF / Share 0.93 1.80 0.31 1.53 1.38 -0.47 -2.63 -4.12 2.17 3.43 0.58 1.49
Operating CF 74.70M 100.70M 32.40M 90.90M 87.30M (2.50M) (74.50M) (145.60M) 144.20M 188.80M 97.60M 147.90M
Total Assets 1.07B 1.15B 1.69B 1.79B 1.60B 1.67B 1.80B 1.83B 2.20B 2.07B 2.00B 2.53B
Total Debt 129.10M 170.20M 209.10M 277.00M 187.50M 248.80M 325.40M 247.70M 580.90M 579.00M 578.10M 636.20M
Cash & Equiv 89.80M 107.70M 87.70M 127.70M 118.50M 111.50M 205.30M 384.50M 219.70M 113.70M 129.50M 149.00M
Book Value 778.20M 828.50M 1.24B 1.29B 1.27B 1.26B 1.27B 1.30B 1.22B 1.10B 1.06B 1.49B
Return on Equity -0.09 -0.47 -0.05 0.04 0.00 -0.02 -0.04 0.04 0.07 0.04 -0.40 0.02
AVNS News
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
Jul 02, 2026 06:00 AM · prnewswire.com
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
Jun 25, 2026 10:00 AM · gurufocus.com
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Jun 24, 2026 11:00 AM · gurufocus.com
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Jun 24, 2026 10:54 AM · businesswire.com
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
Jun 24, 2026 06:50 AM · zacks.com
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
Jun 12, 2026 07:47 AM · prnewswire.com
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—TMHC, CZR, XOMA, and AVNS
Jun 11, 2026 12:16 PM · globenewswire.com
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Jun 04, 2026 08:31 AM · zacks.com
Are CZR, AVNS, GBTG Obtaining Fair Deals for their Shareholders?
Jun 01, 2026 11:26 AM · prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger--AFBI, QXO, BLD, and AVNS
Jun 01, 2026 11:00 AM · gurufocus.com